Nipple reconstruction with cross-linked hyaluronic acid after mastectomy
Official title: Impact of Nipple Reconstruction in Mastectomized Patients Using Cross-Linked Hyaluronic Acid Injection.
Run by Germans Trias i Pujol Hospital · NCT07008339 · Data updated 2026-11-12
This trial will test whether adding a cross-linked hyaluronic acid injection to areola micropigmentation helps women who had a mastectomy achieve better nipple projection, appearance, and satisfaction.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 138 (estimated) |
| Sponsor | Germans Trias i Pujol Hospital Academic / other |
| Locations | 1 site (Badalona, Barcelona) |
| Status | Recruiting |
| Started | June 2, 2023 |
| Main results expected | June 2, 2027 |
| Study ends | July 2, 2029 |
| Registry record updated | June 6, 2025 |
| Trial ID | NCT07008339 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18 or older undergoing their first nipple-areola complex reconstruction with micropigmentation after mastectomy, with no prior neo‑nipple surgery and at least six months since their last breast surgery are ideal candidates.
✕Probably not a fit
Those with known allergy to hyaluronic acid, poor tolerance to needle injections, recent breast surgery (under six months), or who are not seeking nipple reconstruction are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This sequential explanatory mixed-methods project first runs a randomized controlled trial comparing areola micropigmentation alone versus micropigmentation plus hyaluronic acid (HA) nipple injection in 138 participants over 36 months at Germans Trias i Pujol Hospital. Primary outcomes include psychosocial and sexual well-being, satisfaction with breast and nipple appearance (Spanish BREAST-Q and a custom tool), and objective nipple projection measured with calipers. Phase 2 consists of qualitative interviews with a purposive sample of women who received HA to explore personal experiences and meanings of the intervention. The design combines quantitative outcome measurement with qualitative depth to explain how HA injection may affect aesthetic and quality-of-life outcomes.
Why it matters
Potential benefit: If successful, adding HA injection could improve nipple projection and cosmetic satisfaction and lead to better psychosocial and sexual wellbeing after reconstruction.
How similar studies have gone: Use of HA for nipple projection is relatively novel with limited prior data, so rigorous evidence on psychosocial and aesthetic benefits is currently sparse.
Who can join: the full rules
Show full inclusion / exclusion criteria
* Quantitative Phase * Inclusion Criteria: Women over 18 years of age, or with parental or legal guardian consent. At least one of the following criteria: Women undergoing their first nipple-areola complex (NAC) reconstruction through micropigmentation and/or: No previous neo-nipple surgery, either unilaterally or bilaterally. Surgical reconstruction of the areola. Surgical reconstruction of the NAC with subsequent retraction of the neo-nipple. More than 6 months since their last surgery. \- Exclusion Criteria: Allergy to hyaluronic acid. Poor tolerance to needle injections. Withdrawal Criteria: Participant's voluntary decision. Complications associated with the technique (allergy, hematoma, etc.). Clinical deterioration preventing the woman from continuing in the study. \- Qualitative Phase Participant Profile Characteristics: For the qualitative phase, women who have received NAC reconstruction with HA will be invited to participate, following the maximum variation criterion. To ensure the inclusion of participants with diverse characteristics and capture a wide range of perspectives and experiences on the phenomenon under study, women of varying ages, with different breast cancer diagnoses, and histories of various oncological, surgical, and therapeutic treatments will be selected.
Where it's running
-
Hospital Universitario Germans Trias i Pujol
Badalona, Barcelona, Spain Recruiting
Study contacts
- Principal investigator: Isabel Granados Navarrete, RN — Germans Trias i Pujol Hospital
- Study coordinator: Isabel Granados Navarrete, RN
- Email: isabelgranados_navarrete@hotmail.com
- Phone: +34 695161506
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing fat processing methods for breast reconstruction after mastectomy
This study is testing which fat processing method works best for keeping fat grafts in place during breast reconstruction after mastectomy for women who have enough fat to use.
-
Improved Facial Skin Quality After VYC-12L for Breast Cancer Survivors
This study tests whether intradermal injections of VYC-12L can improve facial skin quality and quality of life in adults who have completed breast cancer treatment.
-
Erector spinae plane block for managing pain after breast cancer surgery
This study is testing if a special nerve block combined with a medication can help reduce pain and improve recovery for women after breast cancer surgery.
-
Comparing cosmetic results and patient satisfaction of two breast surgery techniques
This study is trying to see if a newer breast surgery technique gives better cosmetic results and patient satisfaction compared to a traditional method for women under 65 with breast cancer.
-
How a patient experience check-in helps people in intermediate and long-term care feel more trusted in the hospital
This study tests whether identifying and acting on patient concerns in intermediate and long-term care units can help older patients trust the hospital more and reduce complaints.
-
ESP Blocks to Help Pain After Breast Reconstruction with Autologous Flaps
This study tests whether erector spinae plane blocks can improve pain control after autologous free flap breast reconstruction in adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.